Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Collaboration Aims to Develop Novel Generation Artificial Pancreas

November 27, 2015 By Debiotech SA

The artificial pancreas is often presented as the holy grail of diabetes treatment.

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern – and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital “Inselspital” are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas. Combining a fully new control algorithm for the personalized delivery of insulin for diabetic patients with the unequalled accuracy of an MEMS based pump, the three partners’ ambition is to create a substantial change in the treatment of diabetes and in the market for the artificial pancreas.

The artificial pancreas is often presented as the holy grail of diabetes treatment. “Today, a diabetic patient must follow a very constraining therapy with many blood glucose measurements, dose calculations and insulin injections. The ideal would be to have a single system that can conduct all of these operations without requiring any intervention”, says Peter Diem, MD, Professor and Head of the Division of Endocrinology, Diabetes and Clinical Nutrition of the “Inselspital”. On the one hand, such systems require a continuous glucometer that every minute will measure and calculate the level of glucose present in the blood and, on the other hand, an infusion pump that will continuously deliver insulin. The amount of infused insulin is determined by an algorithm that estimates the patient needs based on the measured glucose levels, the time of day or the expected activities and that will adapt the pump infusion rate accordingly. “Approaches taken so far do not resolve fundamental difficulties: the patients’ variability, uncertainties related to system disturbances, e.g. food intake and physical activity, and errors related to the used devices. The proposed algorithm is easy to use, introduces the concept of real-time personalization based on reinforcement learning, a machine learning method, is able to tackle inter- and intra-patient variability, and can compensate for the effects of uncertain events”, says Stavroula Mougiakakou, PhD, Head of the Diabetes Technology Research Group at the ARTORG Center.

The system will include the JewelPUMP developed by Debiotech and the algorithm will run on the wireless PDA device used today for the programming of the pump. “Our objective has always been to bring innovation that can better serve patient needs and improve quality of life”, says Frédéric Neftel, President and CEO of Debiotech. “The JewelPUMP, with its unique accuracy and safety features, offers an ideal platform to develop new approaches for an artificial pancreas. ARTORG has been working for many years on new algorithms, outside the conventional approach, which could open new perspectives for a more intelligent artificial pancreas. We are delighted to enter into this partnership with both clinical experts and engineers in the heart of Switzerland”.

The JewelPUMP is a patch pump, directly placed on the skin, which can be detached and reattached at will. It is waterproof and includes several sensors to continuously monitor therapy. It has been used by patients in a clinical trial for several days at home and its reception has been very enthusiastic. The accuracy of the different elements in an artificial pancreas is critical. The insulin levels have to be maintained in a very narrow window. Too little insulin will lead to hyperglycemia, while too much insulin generates hypoglycaemia. Both situations may induce coma and even patient death. “The scrutiny on pump accuracy has increased in recent years. In vitro and in vivo, the JewelPUMP has shown its ability to inject the programmed dose very accurately. Combining the algorithm developed by ARTORG with Debiotech’s JewelPUMP has the potential to revolutionize the way we approach the Artificial Pancreas”, says Laurent Dominique Piveteau, COO of Debiotech.

After development and integration, the algorithm will be tested in different clinical trials. “We are looking forward to seeing this new approach being used by patients and appreciate how much this may facilitate their treatment. It is even more important to improve their quality of life”, said Christoph Stettler, MD, Professor and newly elected Director of the Division of Endocrinology, Diabetes and Clinical Nutrition at the “Inselspital”.

Related Articles Read More >

A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
A portrait of Dexcom VP of Global Clinical Initiatives Tomas Walker
Dexcom focuses on early diabetes diagnosis as COVID links emerge
A portrait of Proximie CEO Nadine Hachach-Haram
They said it at DeviceTalks Boston

DeviceTalks Weekly.

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech